Survival outcomes after adjuvant radiotherapy for aggressive fibromatosis depend on time frame and nuclear β-catenin

Jae-Sik KIM; Hak-Jae KIM; Me-Yeon LEE; Kyung-Chul MOON; Seung-Geun SONG; Han-Soo KIM; Ilkyu HAN; Il-Han KIM.
Radiation Oncology Journal ; : 37-42, 2019.
Artículo en Inglés | WPRIM | ID: wpr-760991

Documentos relacionados

  1. A Nationwide Prospective Clinical Trial on Active Surveillance in Patients With Non-intraabdominal Desmoid-type Fibromatosis: The GRAFITI Trial.
  2. The Landmark Series: Desmoid.
  3. [Mesogastric desmoid tumor, a rare entity].
  4. Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.
  5. The Role of Reconstruction on Desmoid Tumor Recurrence: A Systematic Review and Technical Considerations.
  6. Percutaneous Cryoablation Provides Disease Control for Extra-Abdominal Desmoid-Type Fibromatosis Comparable with Surgical Resection.
  7. Risk factors for local recurrence of upper extremity desmoid tumors.
  8. Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model.
  9. MR-guided focused ultrasound therapy of extra-abdominal desmoid tumors: a multicenter retrospective study of 105 patients.
  10. The Prognostic Role of ß-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data.